Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC
ClinicalTrials.gov study NCT07026474. IPD Sharing: NO. Countries: 1. Publications: 0.
KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent
ClinicalTrials.gov study NCT05001724. IPD Sharing: NO. Countries: 1. Publications: 0.
SIRT or TACE Plus Lenvatinib and PD-(L)1 Inhibitor in High Burden HCC
ClinicalTrials.gov study NCT06916546. IPD Sharing: NO. Countries: 1. Publications: 0.
Fluid Management Guided by Bioimpedance Analysis in Peritoneal Dialysis(PD) Patients.
ClinicalTrials.gov study NCT02000128. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
ClinicalTrials.gov study NCT07348107. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Clinical Trial of PD-L1 in Combination with Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy with or Without Radiotherapy for Advanced Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06771609. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC
ClinicalTrials.gov study NCT04639284. IPD Sharing: NO. Countries: 1. Publications: 0.
Behavioural Profiling of Disease-related Cognitive and Motor Impairment in PD
ClinicalTrials.gov study NCT06275633. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study to Assess the Effect of Change of Bile Acid on the PD and Safety of Metformin and Microbiome Profiles
ClinicalTrials.gov study NCT04335526. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06366789. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD
ClinicalTrials.gov study NCT02408562. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD
ClinicalTrials.gov study NCT07139236. IPD Sharing: NO. Countries: 1. Publications: 0.
PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects.
ClinicalTrials.gov study NCT01685333. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
ClinicalTrials.gov study NCT06788990. IPD Sharing: Not stated. Countries: 14. Publications: 0.
Vopratelimab and a CTLA-4 Inhibitor in PD-1/PD-L1 Inhibitor Experienced Subjects With NSCLC or Urothelial Cancer
ClinicalTrials.gov study NCT03989362. IPD Sharing: NO. Countries: 2. Publications: 0.
The Cerebellum as a Potential Treatment Site for PD Motor Symptoms
ClinicalTrials.gov study NCT02387346. IPD Sharing: Not stated. Countries: 1. Publications: 0.
White Matter Pathology in Parkinson's Disease (PD)
ClinicalTrials.gov study NCT01039831. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HC010 in First-line PD-L1 Positive Advanced NSCLC Patients
ClinicalTrials.gov study NCT07169552. IPD Sharing: NO. Countries: 1. Publications: 0.
A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment
ClinicalTrials.gov study NCT05198778. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
ClinicalTrials.gov study NCT01155453. IPD Sharing: Not stated. Countries: 5. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.